Beneficial ownership — 13D / 13G
87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Wynnefield Partners Small Cap Value, L.P. I | LFCR Lifecore Biomedical, Inc. De | 13D/A | 16% | Jun 28, 2024 | 2y |
| BAILLIE GIFFORD & CO | DNA Ginkgo Bioworks Holdings, Inc. | 13G/A | 7.87% | Jun 28, 2024 | 2y |
| ALJ Investment Company, LLC | HNRG Hallador Energy Co | 13G | 4.88% | Jun 28, 2024 | 2y |
| Zhang Xiao Mou | HFFG HF Foods Group Inc. | 13D/A | 6.81% | Jun 26, 2024 | 2y |
| Durable Capital Partners LP | DOCS Doximity, Inc. | 13G | 5.1% | Jun 25, 2024 | 2y |
| GIC Private Ltd | EDU New Oriental Education & Technology Group Inc. | 13G | 5.03% | Jun 25, 2024 | 2y |
| Dominion Capital LLC | VSEE Vsee Health, Inc. | 13G | 5.4% | Jun 24, 2024 | 2y |
| Castrol Holdings International Limited | GGR Gogoro Inc. | 13G | 5.72% | Jun 24, 2024 | 2y |
| Altshuler Shaham Ltd | KEN Kenon Holdings Ltd. | 13G/A | 4.99% | Jun 4, 2024 | 2y |
| Mink Brook Asset Management LLC | DLHC DLH Holdings Corp. | 13G | 5.03% | Jul 3, 2024 | 2y |
| Ryan Steelberg | VERI Veritone, Inc. | 13D/A | 13.8% | Jul 3, 2024 | 2y |
| Tempus AI, Inc. | PSNL Personalis, Inc. | 13D | 15.3% | Jul 3, 2024 | 2y |
| Chad Steelberg | VERI Veritone, Inc. | 13D/A | 13.6% | Jul 3, 2024 | 2y |
| LandBridge Holdings LLC | LB LandBridge Corp | 13D | 76.2% | Jul 1, 2024 | 2y |
| Fund 1 Investments, LLC | TLYS Tilly's, Inc. | 13D/A | 35.54% | Jul 1, 2024 | 2y |
| Atlas Investissement SAS | TIGO Millicom International Cellular SA | 13D/A | 29.18% | Jul 1, 2024 | 2y |
| Rehan Jaffer | FUN Six Flags Entertainment Corporation | 13D | 6.6% | Jul 1, 2024 | 2y |
| Stellantis N.V. | ACHR Archer Aviation Inc. | 13D/A | 20.8% | Jul 1, 2024 | 2y |
| 325 CAPITAL LLC | MSAI MultiSensor AI Holdings, Inc. | 13D | 11.6% | Jul 1, 2024 | 2y |
| Mill Road Capital III, L.P. | ALTG Alta Equipment Group Inc. | 13D/A | 11.2% | Jul 1, 2024 | 2y |
| AyurMaya Capital Management Company, LP | ALMS Alumis Inc. | 13D | 22.57% | Jul 1, 2024 | 2y |
| HANSAINVEST Hanseatische Investment-Limited Co | IREN IREN Ltd | 13G | 2.5% | Jun 30, 2024 | 2y |
| KEYBANK NATIONAL ASSOCIATION/OH | JA Janus Detroit Street Trust | 13G/A | 9.09% | Jun 30, 2024 | 2y |
| Nantahala Capital Management, LLC | EGRX Eagle Pharmaceuticals, Inc. | 13G | 15.1% | Jun 30, 2024 | 2y |
| FPR PARTNERS LLC | VISN Vistance Networks, Inc. | 13G/A | 9.2% | Jun 28, 2024 | 2y |
| JPMORGAN CHASE & CO | JBL Jabil Inc | 13G/A | 3.3% | Jun 28, 2024 | 2y |
| JPMORGAN CHASE & CO | ACCD Accolade, Inc. Common Stock | 13G/A | 3.6% | Jun 28, 2024 | 2y |
| JPMORGAN CHASE & CO | MCS Marcus Corp | 13G/A | 3% | Jun 28, 2024 | 2y |
| Mubadala Investment Co PJSC | ARIS Aris Mining Corp | 13G | 9.3% | Jun 28, 2024 | 2y |
| MMCAP International Inc. SPC | TONT Graf Global Corp. | 13G | 8.6% | Jun 27, 2024 | 2y |
| Palantir Technologies Inc. | SRFM Surf Air Mobility Inc. | 13G/A | 12.1% | Jun 27, 2024 | 2y |
| L1 Capital Global Opportunities Master Fund, Ltd. | BJDX Bluejay Diagnostics, Inc. | 13G | 9.99% | Jun 27, 2024 | 2y |
| Pershing Edward | PVCT Provectus Biopharmaceuticals, Inc. | 13D | 5.17% | Jun 26, 2024 | 2y |
| Phoenix Financial Ltd. | RMTHF Magic Software Enterprises Ltd | 13G/A | 4.92% | Jun 26, 2024 | 2y |
| Xiande Li | JKS Jinko Holdings Ltd | 13D/A | 19.5% | Jun 21, 2024 | 2y |
| Octagon Capital Advisors LP | ANTX AN2 Therapeutics, Inc. | 13G | 10.1% | Jun 13, 2024 | 2y |
| Weilai Zhang | AEHL Antelope Enterprise Holdings Ltd | 13D/A | 85.37% | May 31, 2024 | 2y |
| CHRISTOPHER McEACHNIE | CAHO Caro Holdings Inc. | 13D/A | 91.99% | Apr 28, 2022 | 2y |
| CoyCo GP, L.L.C. | RCM R1 RCM Inc. Common Stock | 13D/A | 32.3% | Jul 2, 2024 | 2y |
| SANDERS MORRIS HARRIS LLC | MSAI MultiSensor AI Holdings, Inc. | 13G/A | 20.9% | Jul 2, 2024 | 2y |
| Point72 Asset Management, L.P. | LITE Lumentum Holdings Inc. | 13G | 5% | Jul 1, 2024 | 2y |
| Peter J. Werth | CING Cingulate Inc. | 13D/A | 12.57% | Jul 1, 2024 | 2y |
| Vantage Consulting Group Inc | AMOM Exchange Listed Funds Trust | 13G/A | 57.16% | Jun 30, 2024 | 2y |
| NEUBERGER BERMAN GROUP LLC | ATRI Atrion Corp | 13G/A | 2.25% | Jun 30, 2024 | 2y |
| KING LUTHER CAPITAL MANAGEMENT CORP | SCPH scPharmaceuticals Inc. Common Stock | 13G/A | 6.4% | Jun 30, 2024 | 2y |
| Brookstone Capital Management | AAPR Innovator ETFs Trust | 13G | 19.08% | Jun 30, 2024 | 2y |
| KING LUTHER CAPITAL MANAGEMENT CORP | TXO TXO Partners, L.P. | 13G/A | 8.8% | Jun 30, 2024 | 2y |
| Brookstone Capital Management | AAPR Innovator ETFs Trust | 13G | 10.16% | Jun 30, 2024 | 2y |
| Thompson Dean (VOLUNTARY) | OABI OmniAb, Inc. | 13D/A | 21.1% | Jun 28, 2024 | 2y |
| Peter Yu | THCH TH International Ltd | 13D/A | 63.5% | Jun 28, 2024 | 2y |